RecruitingChronic Rhinosinusitis (CRS) With and Without Nasal Polyps
Paclitaxel-Coated Balloon Treatment of Chronic Rhinosinusitis
Eligible age
18+ yrs
Accepts
All genders
Locations
11 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
This is a prospective, multicenter, randomized, controlled, double-blind clinical trial enrolling 300 adult subjects with chronic rhinosinusitis (CRS) with and without nasal polyps (CRSwNP and CRSsNP) indicated for endoscopic sinus surgery (ESS).
Sponsor: Airiver Medical, Inc.
You may qualify if…
- ✓ 1. Male or female, aged ≥18 years
- ✓ 2. Confirmed diagnosis of CRS per the 2021 "International Consensus Statement on Allergy and Rhinology: Rhinosinusitis" definition.
- ✓ 3. Radiographic evidence of bilateral ethmoid disease on CT taken 6 months or less prior to study index procedure and at least 6 months after any prior ESS or nasal surgery, polypectomy, balloon sinus dilation, etc. as applicable
- ✓ 4. Radiographic evidence of bilateral frontal sinus and/or frontal sinus outflow tract disease
- ✓ 5. Baseline SNOT-22 score ≥ 30
- ✓ 6. Has failed previous medical treatment and is an appropriate candidate for primary or revision ESS of bilateral ethmoid sinuses and bilateral frontal/frontal sinus outflow tract
- ✓ 7. Willing and able to provide written informed consent
- ✓ 8. Willing and able to comply with all protocol follow up visits and assessments
You may not qualify if…
- ✕ 1. Nasal cavity tumor (malignant or benign)
- ✕ 2. Antrochoanal polyps
- ✕ 3. Previous complete middle turbinate resection
- ✕ 4. Clinical evidence or suspicion of invasive fungal sinusitis (e.g., bone erosion on CT scan, necrotic sinus tissue)
- ✕ 5. History of prior lamina dehiscence or cerebrospinal fluid (CSF) leak in skull-based dehiscence
- ✕ 6. Concurrent condition requiring active chemotherapy and/or immunotherapy management
- ✕ 7. Subjects whose symptoms are too severe to undergo ESS (e.g., temperature \>102.5F or extra-sinus manifestations, such as orbital cellulitis; dental or facial or brain abscess; cavernous vein thrombosis; or altered mental status
- ✕ 8. History of complications from prior ESS or balloon dilation procedure (e.g., CSF leak or injury to the skull base or orbital injury)
Where it's recruiting
Alabama
Birmingham · Huntsville
California
San Diego
Colorado
Colorado Springs
Iowa
Cedar Rapids
Kansas
Kansas City
Kentucky
Louisville
New York
The Bronx
Pennsylvania
Philadelphia
South Carolina
Charleston
Texas
Dallas · Fort Worth · McKinney
Virginia
Charlottesville
Source: ClinicalTrials.gov · NCT07290140 · last updated 2026-10-29